Abstract

It is aimed to evaluate portal dosimetry results of planned breast cancer patients with intensity-modulated radiotherapy (YART) of Anisotropic Analytical Algorithm (AAA) and Pencil Beam Convolution (PBC) dose calculation algorithms. The plans of 10 treated patients will receive 6 MV photon energy and a total of 25 fractions of 50 Gray dose using the inverse YART technique, which is reverse planned in the Eclipse (ver.13.6) treatment planning system with Varian Trilogy Linear Accelerator prescribing. For each plan, dose was calculated after optimization using PBC and then AAA algorithms. The quality controls of the plans were made using the Electronic Portal Imaging Device (EPID) by creating individual verification plans for each algorithm. In addition, the maximum and average dose values in the target volume were compared in inverse YART plans calculated using PBC and AAA. When treatment plans generated by AAA and PBC dose calculation algorithms are analyzed using EPID, for the PBC algorithm, the mean values of VArea and VAvg are 98.15 ± 1.07, 0.40 ± 0.048 and 98.72 ± 1.13, 0.37 ± 0.051, respectively, for the AAA algorithm. The PTV Dmax value for the PBC algorithm is 109.3 ± 1.09 and the DAvg value is 101.7 ± 0.51. For the AAA algorithm, the PTV Dmax value is 110.6 ± 1.12 and the DAvg value is 102.9 ± 0.62. When the mean values of portal dosimetry VArea and VAvg evaluated using PBC and AAA algorithms were compared, the differences between the algorithms were not statistically significant (p> 0.05). Differences between the algorithms for PTV Dmax and DAvg values are not statistically significant (p> 0.05).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.